BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 25255101)

  • 1. Cathepsin B in antigen-presenting cells controls mediators of the Th1 immune response during Leishmania major infection.
    Gonzalez-Leal IJ; Röger B; Schwarz A; Schirmeister T; Reinheckel T; Lutz MB; Moll H
    PLoS Negl Trop Dis; 2014 Sep; 8(9):e3194. PubMed ID: 25255101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cathepsin L is crucial for a Th1-type immune response during Leishmania major infection.
    Onishi K; Li Y; Ishii K; Hisaeda H; Tang L; Duan X; Dainichi T; Maekawa Y; Katunuma N; Himeno K
    Microbes Infect; 2004 Apr; 6(5):468-74. PubMed ID: 15109961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsin B-Deficient Mice Resolve Leishmania major Inflammation Faster in a T Cell-Dependent Manner.
    Rasid O; Mériaux V; Khan EM; Borde C; Ciulean IS; Fitting C; Manoury B; Cavaillon JM; Doyen N
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004716. PubMed ID: 27182703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cell differentiation state and their interaction with NKT cells determine Th1/Th2 differentiation in the murine model of Leishmania major infection.
    Wiethe C; Debus A; Mohrs M; Steinkasserer A; Lutz M; Gessner A
    J Immunol; 2008 Apr; 180(7):4371-81. PubMed ID: 18354157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leishmania major-infected murine langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous Leishmaniasis.
    von Stebut E; Belkaid Y; Nguyen BV; Cushing M; Sacks DL; Udey MC
    Eur J Immunol; 2000 Dec; 30(12):3498-506. PubMed ID: 11093169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cathepsins B, L and D in inflammatory bowel disease macrophages and potential therapeutic effects of cathepsin inhibition in vivo.
    Menzel K; Hausmann M; Obermeier F; Schreiter K; Dunger N; Bataille F; Falk W; Scholmerich J; Herfarth H; Rogler G
    Clin Exp Immunol; 2006 Oct; 146(1):169-80. PubMed ID: 16968411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cells (DC) activated by CpG DNA ex vivo are potent inducers of host resistance to an intracellular pathogen that is independent of IL-12 derived from the immunizing DC.
    Ramírez-Pineda JR; Fröhlich A; Berberich C; Moll H
    J Immunol; 2004 May; 172(10):6281-9. PubMed ID: 15128817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PKCδ regulates IL-12p40/p70 production by macrophages and dendritic cells, driving a type 1 healer phenotype in cutaneous leishmaniasis.
    Guler R; Afshar M; Arendse B; Parihar SP; Revaz-Breton M; Leitges M; Schwegmann A; Brombacher F
    Eur J Immunol; 2011 Mar; 41(3):706-15. PubMed ID: 21287553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double deficiency of cathepsins B and L results in massive secretome alterations and suggests a degradative cathepsin-MMP axis.
    Tholen S; Biniossek ML; Gansz M; Ahrens TD; Schlimpert M; Kizhakkedathu JN; Reinheckel T; Schilling O
    Cell Mol Life Sci; 2014 Mar; 71(5):899-916. PubMed ID: 23811845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with cathepsin L inhibitor potentiates Th2-type immune response in Leishmania major-infected BALB/c mice.
    Zhang T; Maekawa Y; Sakai T; Nakano Y; Ishii K; Hisaeda H; Dainichi T; Asao T; Katunuma N; Himeno K
    Int Immunol; 2001 Aug; 13(8):975-82. PubMed ID: 11470767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of cysteine cathepsins B or L yields differential impacts on murine skin proteome and degradome.
    Tholen S; Biniossek ML; Gansz M; Gomez-Auli A; Bengsch F; Noel A; Kizhakkedathu JN; Boerries M; Busch H; Reinheckel T; Schilling O
    Mol Cell Proteomics; 2013 Mar; 12(3):611-25. PubMed ID: 23233448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirements for Th1-dependent immunity against infection with Leishmania major.
    von Stebut E; Udey MC
    Microbes Infect; 2004 Oct; 6(12):1102-9. PubMed ID: 15380780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switch of CD4+ T cell differentiation from Th2 to Th1 by treatment with cathepsin B inhibitor in experimental leishmaniasis.
    Maekawa Y; Himeno K; Ishikawa H; Hisaeda H; Sakai T; Dainichi T; Asao T; Good RA; Katunuma N
    J Immunol; 1998 Sep; 161(5):2120-7. PubMed ID: 9725203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical role of dendritic cells in determining the Th1/Th2 balance upon Leishmania major infection.
    Suzue K; Kobayashi S; Takeuchi T; Suzuki M; Koyasu S
    Int Immunol; 2008 Mar; 20(3):337-43. PubMed ID: 18195051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MHC class II expression restricted to CD8alpha+ and CD11b+ dendritic cells is sufficient for control of Leishmania major.
    Lemos MP; Esquivel F; Scott P; Laufer TM
    J Exp Med; 2004 Mar; 199(5):725-30. PubMed ID: 14993255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In experimental leishmaniasis deficiency of CD18 results in parasite dissemination associated with altered macrophage functions and incomplete Th1 cell response.
    Schönlau F; Scharffetter-Kochanek K; Grabbe S; Pietz B; Sorg C; Sunderkötter C
    Eur J Immunol; 2000 Sep; 30(9):2729-40. PubMed ID: 11009109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for leukocyte-derived IL-1RA in DC homeostasis revealed by increased susceptibility of IL-1RA-deficient mice to cutaneous leishmaniasis.
    Kautz-Neu K; Kostka SL; Dinges S; Iwakura Y; Udey MC; von Stebut E
    J Invest Dermatol; 2011 Aug; 131(8):1650-9. PubMed ID: 21525884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmania major phosphoglycans influence the host early immune response by modulating dendritic cell functions.
    Liu D; Kebaier C; Pakpour N; Capul AA; Beverley SM; Scott P; Uzonna JE
    Infect Immun; 2009 Aug; 77(8):3272-83. PubMed ID: 19487470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cure of progressive murine leishmaniasis: interleukin 4 dominance is abolished by transient CD4(+) T cell depletion and T helper cell type 1-selective cytokine therapy.
    Heinzel FP; Rerko RM
    J Exp Med; 1999 Jun; 189(12):1895-906. PubMed ID: 10377185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of cysteine proteases cathepsin B and cathepsin L in pancreatic adenocarcinoma.
    Niedergethmann M; Wostbrock B; Sturm JW; Willeke F; Post S; Hildenbrand R
    Pancreas; 2004 Oct; 29(3):204-11. PubMed ID: 15367886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.